NP
BSX icon

NorthRock Partners’s Boston Scientific BSX Stock Holding History

NorthRock Partners’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-2,118
Closed -$202K – 687
2025
Q4 		$202K Sell
2,118
-17,113
-89% -$1.68M ﹤0.01% 581
2025
Q3 		$1.88M Buy
19,231
+4,284
+29% +$444K 0.03% 223
2025
Q2 		$1.61M Sell
14,947
-1,533
-9% -$155K 0.04% 163
2025
Q1 		$1.66M Buy
16,480
+217
+1% +$21.9K 0.06% 139
2024
Q4 		$1.45M Sell
16,263
-660
-4% -$58.1K 0.05% 152
2024
Q3 		$1.42M Buy
16,923
+2,030
+14% +$160K 0.05% 169
2024
Q2 		$1.15M Buy
14,893
+702
+5% +$51.4K 0.04% 180
2024
Q1 		$972K Buy
14,191
+517
+4% +$33.2K 0.04% 208
2023
Q4 		$790K Buy
13,674
+6,152
+82% +$328K 0.03% 227
2023
Q3 		$397K Buy
7,522
+1,391
+23% +$73K 0.04% 191
2023
Q2 		$332K Sell
6,131
-717
-10% -$37.4K 0.04% 199
2023
Q1 		$343K Sell
6,848
-240
-3% -$11.3K 0.04% 201
2022
Q4 		$328K Buy
+7,088
New +$307K 0.04% 231
2022
Q2 		– Sell
-6,614
Closed -$293K – 312
2022
Q1 		$293K Buy
6,614
+1,819
+38% +$78.8K 0.03% 247
2021
Q4 		$204K Buy
+4,795
New +$201K 0.02% 315
2016
Q4 		– Sell
-13,587
Closed -$323K – 58
2016
Q3 		$323K Sell
13,587
-1,543
-10% -$36.8K 0.14% 28
2016
Q2 		$354K Buy
15,130
+12,119
+402% +$262K 0.16% 27
2016
Q1 		$56K Buy
+3,011
New +$52.9K 0.03% 47
2015
Q3 		– Sell
-22,403
Closed -$397K – 46
2015
Q2 		$397K Sell
22,403
-3,465
-13% -$61.9K 0.18% 29
2015
Q1 		$459K Buy
25,868
+1,750
+7% +$27.7K 0.27% 24
2014
Q4 		$320K Buy
+24,118
New +$308K 0.2% 28

Other funds holding BSX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

NorthRock Partners's BSX Position: Q1 2026 in Review

NorthRock Partners sold out of Boston Scientific (BSX) in Q1 2026, closing a stake of 2,118 shares — an estimated $202K sold.

NorthRock Partners first reported a position in BSX in Q4 2014 and held it in 21 quarters. The position peaked at $1.88M in Q3 2025. 1,666 funds tracked by Wall St. Rank hold BSX as of Q1 2026.

  • NorthRock Partners reported no remaining Boston Scientific position as of Q1 2026 after selling out during the quarter.
  • NorthRock Partners sold 2,118 Boston Scientific shares in Q1 2026, an estimated $202K.
  • NorthRock Partners first reported a position in Boston Scientific in Q4 2014 and held it in 21 quarters.
  • NorthRock Partners's Boston Scientific position peaked at $1.88M in Q3 2025.
  • 1,666 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2026.

Based on NorthRock Partners's 13F filing for Q1 2026, filed 15 May 2026.